Acute Hepatitis A

  • Erica Patricia Turse
  • Brett Rossow
  • Veysel TahanEmail author


Several types of viral hepatitis exist including hepatitis A, B, C, D, E, and G. Hepatitis A virus is a virus part of the Picornaviridae family causing 114 million infections worldwide annually. Despite it being a self-limiting systemic disease it presents with a broad manifestation of symptoms, clinical presentation, and complications. Children are more likely to be asymptomatic with adults experiencing symptoms such as jaundice and fatigue leading to possible complications as acute liver failure as age of infection increases. Several methods of vaccination, pre-exposure prophylaxis (PreEP), and postexposure prophylaxis (PeP) for the virus exist.


Hepatitis A virus Hepatitis HAV Viral hepatitis Acute hepatitis Jaundice Hepatitis A vaccinations 


  1. 1.
    Tahan V, Ozdogon O, Tozun N. Epidemiology of viral hepatitis in the Mediterranean basin. Rocz Akad Med Bialymst. 2003;48:11–7.PubMedGoogle Scholar
  2. 2.
    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602. Scholar
  3. 3.
    Matheny SC, Kingery JE. Hepatitis A. Am Fam Physician. 2012;86(11):1027–34. Scholar
  4. 4.
    Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–7. Scholar
  5. 5.
    Brundage SC, Fitzpatrick NA. Hepatitis A. Am Fam Physician. 2006;73(12):2162–8. Scholar
  6. 6.
    Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):68–73. Scholar
  7. 7.
    Carrillo SP, Tavoschi L, Severi E, Bonfigli S, Edelstein M, Bystrom E, Lopalco P. Seroprevalence and susceptibility to hepatitis A in the European union and European economic area: a systematic review. Lancet Infect Dis. 2017;17(10):e306–19. Scholar
  8. 8.
    Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol. 1985;122(2):226–33.CrossRefGoogle Scholar
  9. 9.
    Vaughan G, Maria L, Rossi G, Forbi JC, Paula VA, Purdy MA, Xia G, Khudyakov YE. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol. 2014;21:227–43. Scholar
  10. 10.
    World Health Organization: Hepatitis A [Internet]. (2017). Accessed 24 Nov 2017.
  11. 11.
    Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28(5):488–96. Scholar
  12. 12.
    Mbithi JN, Sprinthorpe VS, Boulet JR, Sattari SA. Survival of Hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J Clin Microbiol. 1992;30(4):757–63.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Hutin YJ, Pool V, Cramer EH, Nainan OV, Weth J, Williams IT, Goldstein ST, Gensheimer KF, Bell BP, Shapiro CN, Alter MJ, Margolis HS. A multistate, foodborne outbreak of hepatitis A. N Engl J Med. 1999;340(8):595–602. Scholar
  14. 14.
    Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001;14(1):38–58. Scholar
  15. 15.
    Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics. 2002;109:839–45. Scholar
  16. 16.
    Koslap-Petraco MB, Shub M, Judelsohn R. Hepatitis A: disease burden and current childhood vaccination strategies in the United States. J Pediatr Health Care. 2008;22(1):3–11. Scholar
  17. 17.
    Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367–79. Scholar
  18. 18.
    Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A: review of 14 cases and literature survey. Medicine. 1992;71(1):14–23. Scholar
  19. 19.
    Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286–90. Scholar
  20. 20.
    Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med. 2005;118(Suppl 10A):75S–83S. Scholar
  21. 21.
    Sarawgi S, Gupta AK, Arora DS, Jasuja S. Acute renal failure associated with nonfulminant acute viral hepatitis A. Indian J Nephrol. 2008;18(2):77–9. Scholar
  22. 22.
    Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R. Autoimmune hepatitis induced by the prolonged hepatitis A virus infection. Ann Hepatol. 2008;7(20):177–9.PubMedGoogle Scholar
  23. 23.
    Atlanta (GA): Centers for Disease Control and Prevention (US): Hepatitis A questions and answers for health professionals [Internet]. (2017). Accessed 8 Nov 2017. [cited 2017 Nov 22].

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Erica Patricia Turse
    • 1
  • Brett Rossow
    • 1
  • Veysel Tahan
    • 1
    Email author
  1. 1.Division of GastroenterologyUniversity of MissouriColumbiaUSA

Personalised recommendations